LITSLite Strategy
Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel and differentiated cancer therapies. 10-K, Item 1
- Headquarters
- San Diego, CA
- CEO
- Justin J. File
- Next results
- around Feb 16, 2027
FY2026 in six numbers
The latest figures
All key numbers (27) From EDGAR
| EPS (ttm) | -1.46 | Sales (ttm) | 0 | Net income (ttm) | -51.5M | Sales growth | - | EPS growth | - | Sales Q/Q | - |
| Free cash flow | - | Gross margin | - | Oper. margin | - | Net margin | - | FCF margin | - | ROE | -90.8% |
| ROA | -88.2% | R&D / sales | - | Dividend | - | Debt/Eq | - | Curr. ratio | 3.64 | Cash | 4.3M |
| Op. cash flow (ttm) | -6.8M | EBITDA | -66.6M | Quick ratio | 3.64 | Shares out. | 29.9M | Shares Y/Y | +3.7% | Book / share | 1.90 |
| Cash / share | 0.14 | Sales / share | 0.00 | Asset turnover | 0.00 |
Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.
LITS against Crypto peers
Ten years, side by side → · All 32 →Each side 0 to 100, ranked against every company we cover: relative position on reported figures, not a buy score. How
Every dot is one of the 32 companies, the better end on the right. Hover a dot for the company.
| Company | Revenue (ttm) | Sales growth | Gross margin | Net margin | ROE | FCF margin | Debt / equity |
|---|---|---|---|---|---|---|---|
| LITS Lite Strategy | $0 | - | - | - | -90.8% | - | - |
| TRON Tron Inc. | $5.1M | +10.0% | 25.7% | - | 3.6% | - | - |
| ASST Strive | $3.6M | - | - | -591.2% | -1.5% | -592.3% | - |
| SUIG SUI Group | $2.4M | +18.1% | - | - | -197.9% | - | - |
| NAKA Nakamoto | $1.8M | -33.0% | - | - | -177.9% | - | - |
| HYPD Hyperion DeFi | $1.4M | - | - | - | 6.5% | - | 0.06 |
Profitability
0 of 2- !Return on equity below 15%-90.8%
- !A profit in 2 of 10 years
Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.
Revenue and net income, FY2017 to FY2026
Revenue 0 Net income -71.2MFrom XBRL in each 10-K. Hover a bar for the line item and filing. Full financials →
Income statement, balance sheet and cash flow
LITS's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.
Income statement
From EDGAR| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.2M | 1.6M | 4.9M | 27.8M | 34.8M | 40.7M | 48.8M | 65.3M | 0 | 0 |
| Cost of revenue | 5.0M | 3.4M | 4.3M | 2.7M | 1.4M | 0 | - | - | - | - |
| R&D | 7.2M | 17.0M | 32.3M | 34.1M | 69.4M | 85.6M | 52.5M | 16.6M | 3.9M | 122K |
| SG&A | 8.6M | 9.8M | 14.6M | 16.7M | 24.4M | 30.5M | 33.1M | 23.3M | 13.5M | 12.0M |
| Operating income | 2.4M | -28.6M | -46.2M | -25.7M | -60.4M | -75.5M | -36.8M | 14.5M | -17.5M | -66.6M |
| Pretax income | 2.7M | -40.1M | -16.8M | -47.2M | -41.3M | -54.5M | -31.8M | 17.8M | -15.9M | -71.2M |
| Income tax | 1K | 1K | 1K | 1K | 8K | 0 | 0 | 0 | 0 | 0 |
| Net income | 2.7M | -40.1M | -16.8M | -47.2M | -41.0M | -54.0M | -32.0M | 18.0M | -15.9M | -71.2M |
| EPS (diluted) | 1.40 | -19.40 | -15.00 | -10.40 | -12.00 | -9.99 | -4.78 | 2.67 | -2.39 | -2.06 |
| Diluted shares | 1.8M | 2.1M | 3.6M | 4.6M | 5.7M | 6.3M | 6.7M | 6.7M | 6.7M | 34.6M |
| Depreciation & amortization | 85K | 53K | 80K | 109K | 285K | 326K | 386K | 383K | 368K | 0 |
| EBITDA | 2.5M | -28.5M | -46.2M | -25.6M | -60.1M | -75.2M | -36.4M | 14.9M | -17.1M | -66.6M |
| Operating margin | 10.3% | -1762.4% | -940.9% | -92.6% | -173.7% | -185.5% | -75.3% | 22.3% | - | - |
| Net margin | 11.5% | -2470.3% | -342.2% | -170.0% | -117.8% | -132.7% | -65.6% | 27.6% | - | - |
| Revenue growth | - | -93.0% | +203% | +465% | +25.4% | +17.0% | +19.9% | +33.8% | -100% | - |
| EPS growth | - | -1486% | - | - | - | - | - | - | -190% | - |
Balance sheet
From EDGAR| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | 8.5M | 13.3M | 9.6M | 12.3M | 8.5M | 15.7M | 16.9M | 3.7M | 18.0M | 5.7M |
| Short-term investments | 45.1M | 89.4M | 64.9M | 170.3M | 144.9M | 137.5M | 83.8M | 34.6M | 0 | - |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - |
| Current assets | 55.3M | 104.3M | 82.2M | 208.6M | 164.8M | 167.1M | 107.5M | 40.8M | 18.3M | 6.1M |
| Property & equipment | 50K | 32K | 204K | 1.1M | 1.5M | 1.7M | 1.3M | 392K | 0 | - |
| Total assets | 55.7M | 104.7M | 82.7M | 209.7M | 174.1M | 177.8M | 120.8M | 41.4M | 18.3M | 42.7M |
| Accounts payable | 585K | 3.6M | 4.8M | 2.4M | 6.4M | 7.9M | 6.1M | 3.2M | 176K | 261K |
| Current liabilities | 4.9M | 7.9M | 14.3M | 13.8M | 20.2M | 24.4M | 20.3M | 8.4M | 1.4M | 1.1M |
| Total liabilities | 4.9M | 54.2M | 34.7M | 132.7M | 124.6M | 125.4M | 96.2M | 8.4M | 1.4M | 1.1M |
| Shareholders' equity | 50.8M | 50.5M | 47.9M | 77.1M | 49.5M | 52.4M | 24.6M | 33.0M | 16.9M | 41.6M |
| Retained earnings | -174.3M | -214.4M | -231.2M | -278.4M | -319.7M | -374.2M | -406.0M | -388.2M | -404.2M | -475.3M |
Cash flow
From EDGAR| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.5M | -21.0M | -29.4M | 34.3M | -32.0M | -48.7M | -52.5M | -50.5M | -20.8M | -9.1M |
| Capital spending | 51K | - | 217K | 894K | 708K | 479K | 35K | 7K | 0 | - |
| Free cash flow | 3.4M | - | -29.6M | 33.4M | -32.7M | -49.2M | -52.5M | -50.5M | -20.8M | - |
| Stock-based pay (added back) | 2.3M | 3.2M | 6.6M | 6.8M | 10.2M | 8.3M | 3.6M | 2.3M | -144K | 1.3M |
| Dividends paid | - | - | - | - | - | - | 0 | 11.7M | 0 | - |
| Buybacks | - | - | - | - | - | - | - | - | 0 | 4.9M |
| Investing cash flow | -10.1M | -44.3M | 24.3M | -106.3M | 24.7M | 6.9M | 53.7M | 49.1M | 35.1M | -95.1M |
| Financing cash flow | 4.2M | 70.2M | 1.4M | 74.8M | 3.5M | 49.1M | -40K | -11.9M | 0 | 91.9M |
| Dividend per share | - | - | - | - | - | - | - | 1.75 | - | - |
Stock-based pay and leases
From EDGAR| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based pay (expense) | 2.3M | 3.2M | 6.6M | 6.8M | 10.2M | 8.3M | 3.6M | 2.3M | -144K | 1.3M |
| Stock-based pay / revenue | 9.9% | 198.3% | 133.5% | 24.5% | 29.4% | 20.5% | 7.4% | 3.5% | - | - |
| Operating lease cost | - | - | 685K | 692K | 1.5M | 1.6M | - | - | - | - |
| Operating lease cash paid | - | - | - | - | - | 1.5M | 2.3M | 13.6M | 0 | - |
| Right-of-use assets | - | - | - | 0 | 7.8M | 9.1M | 12.0M | 214K | 0 | - |
| Operating lease liabilities | - | - | - | 0 | 8.3M | 9.6M | 12.7M | 0 | - | - |
From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.
Work on LITS in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/LITS/export.csv") into a cell.